Yikon Genomics is a leading solution-based single cell sequencing company. Currently based on the patented MALBAC¨ technology from Harvard University, Yikon provides complete solutions in the fields of reproductive health and cancer diagnostics with liquid tumor biopsy. The MALBAC-PGSª and MALBAC-PGDª solutions offer the most accurate and comprehensive embryo testing results for physicians to choose the best embryos with balanced chromosomal copy numbers,without inheriting the known disease-associated alleles. Founded by Sunney Xie in 2012, Yikon Genomics is backed by investors that include Guangzhou Yuexiu Industrial Investment Fund, KingMed Diagnostics, Wuhan Zhongyuan Huadian Science & Technology, and Yuexiu Group and is headquartered in Minhang.